Respiratory Therapy Home Market

• Nebulizers

$100 million annual U.S. sales of nebulizers

$550 million in drug ampoules for use with nebulizers

Bronchodilators, Steroids, Mucolytics

• Inhalers

  $2.8 billion in inhaled prescription drugs in U.S.
  
  Bronchodilators, Steroids, Mucolytics
  

• Drugs in development / new to inhalation

  Well over $1 billion market potential
  
  • Long-acting beta-agonists
  • Anti-inflammatory agents
  • Antibiotics
  • Cytokine modulators
  • Gene therapy
  • Protease inhibitors

Previous slide

Next slide

Back to first slide

View graphic version